688658 悅康藥業
按盤價 
16.800 -2.840 (-14.460%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 5.784 | 4.878 | 8.472 | 14.533 | 18.810 |
| 總資產報酬率 ROA (%) | 3.520 | 3.101 | 5.712 | 9.752 | 9.909 |
| 投入資產回報率 ROIC (%) | 4.731 | 4.152 | 7.546 | 13.012 | 11.001 | 邊際利潤分析 |
| 銷售毛利率 (%) | 60.378 | 62.671 | 64.645 | 69.242 | 66.015 |
| 營業利潤率 (%) | 8.522 | 5.523 | 7.881 | 12.824 | 11.343 |
| 息稅前利潤/營業總收入 (%) | 8.417 | 5.076 | 6.976 | 12.006 | 12.323 |
| 淨利潤/營業總收入 (%) | 6.959 | 4.468 | 7.462 | 10.950 | 10.224 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 105.419 | 105.690 | 99.087 | 103.019 | 92.327 |
| 價值變動淨收益/利潤總額(%) | 0.000 | -0.451 | 1.138 | 0.641 | 0.000 |
| 營業外收支淨額/利潤總額(%) | -2.699 | -3.800 | -2.407 | -1.200 | 0.603 | 償債能力分析 |
| 流動比率 (X) | 1.944 | 1.603 | 2.054 | 2.417 | 2.188 |
| 速動比率 (X) | 1.519 | 1.262 | 1.665 | 2.041 | 1.835 |
| 資產負債率 (%) | 38.839 | 39.139 | 33.474 | 31.426 | 34.288 |
| 帶息債務/全部投入資本 (%) | 17.148 | 13.630 | 10.935 | 5.554 | -- |
| 股東權益/帶息債務 (%) | 467.427 | 612.764 | 792.225 | 1,651.120 | 833.064 |
| 股東權益/負債合計 (%) | 157.116 | 155.074 | 198.333 | 218.025 | 191.380 |
| 利息保障倍數 (X) | 71.229 | -20.734 | -9.695 | -18.029 | 13.512 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 76.894 | 91.007 | 81.032 | 50.078 | 0.000 |
| 存貨周轉天數 (天) | 168.214 | 168.463 | 153.642 | 148.364 | 0.000 |
| 備註： | 即時報價更新時間為 23/12/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
